USA Financial Formulas’s ANI Pharmaceuticals ANIP Stock Holding History

USA Financial Formulas’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$39K	Buy	+537	New	+$41.3K	0.01%	268
2023 Q4	–	Sell	-49	Closed	-$2.84K	–	353
2023 Q3	$2.84K	Sell	49 -5	-9%	-$289	﹤0.01%	306
2023 Q2	$2.91K	Buy	+54	New	+$2.39K	﹤0.01%	272
2019 Q4	–	Sell	-7	Closed	-$1K	–	226
2019 Q3	$1K	Buy	+7	New	+$524	﹤0.01%	190
2015 Q1	–	Sell	-10,446	Closed	-$589K	–	184
2014 Q4	$589K	Buy	+10,446	New	+$461K	0.2%	92

Other funds holding ANIP

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

Ranger Investment Management Dallas, Texas $1.07B AUM 31.98% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Penn Capital Management Philadelphia, Pennsylvania $1.37B AUM 42.56% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Dana Investment Advisors Waukesha, Wisconsin $3.69B AUM 30.1% 1-Year Est. Return

USA Financial Formulas's ANIP Position: Q3 2026 in Review

USA Financial Formulas opened a new position in ANI Pharmaceuticals (ANIP) in Q3 2026: 537 shares worth $39K. The stake represents 0.01% of the portfolio and ranks #268 among its holdings. This is a return to the name: USA Financial Formulas previously reported a position in ANIP as recently as Q3 2023.

USA Financial Formulas first reported a position in ANIP in Q4 2014 and has held it in 5 quarters since. The position peaked at $589K in Q4 2014. 112 funds tracked by Wall St. Rank hold ANIP as of Q3 2026.

USA Financial Formulas held 537 shares of ANI Pharmaceuticals worth $39K as of Q3 2026.
ANI Pharmaceuticals was a new USA Financial Formulas position in Q3 2026.
ANI Pharmaceuticals made up 0.01% of USA Financial Formulas's portfolio in Q3 2026, its #268 holding.
USA Financial Formulas first reported a position in ANI Pharmaceuticals in Q4 2014 and has held it in 5 quarters since.
USA Financial Formulas's ANI Pharmaceuticals position peaked at $589K in Q4 2014.
112 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2026.

Based on USA Financial Formulas's 13F filing for Q3 2026, filed 16 Oct 2026.